Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-03-30 @ 7:01 AM
Study NCT ID:
NCT01165112
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2010-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
Sponsor:
University of Washington
Organization: